ZytoLight ® SPEC TP53/ATM Dual Color Probe

The ZytoLight ® SPEC TP53/ATM Dual Color Probe is designed for the detection of deletions affecting the genes TP53 and ATM. Chronic lymphocytic leukemia is the most common form of leukemia in Western population. TP53 gene deletions have been detected in patients with CLL, multiple myeloma, and acute myeloid leukemia. In CLL patients, allelic loss of the short arm of chromosome 17 is associated with treatment failure with alkylating agents and short survival times.

Probe Maps


Ordering Information

Prod. No.:Tests¹ (Volume):Registration Status²:
5 (50 µl)
20 (200 µl)

Download Information


1 Using 10 μl probe solution per test.
2 In vitro diagnostic medical device according to EU directive 98/79/EC. 
CE IVD only available in certain countries. All other countries research use only! 
Please contact your local dealer for more information.

ISO 9001
ISO 13485
ZytoVision GmbH


For ZytoVision products additional information is available, which is only valid outside the United States of America (USA). With this action you confirm that you have read this legal notice, that you agree with the terms of use, and that you are not intending to use the information provided on this website within USA.

Accept & Continue